| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Revenue | $735.8M | +2.9% |
| Cost of Revenue | $260.7M | +13.4% |
| Gross Profit | $475.0M | -2.1% |
| R&D Expense | $113.0M | -8.3% |
| SG&A Expense | $90.7M | +10.1% |
| Operating Income | $18.9M | +24.6% |
| Interest Expense | $18.7M | -35.2% |
| Pre-tax Income | $3.5M | +114.7% |
| Income Tax | $1.9M |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.3M | +5.9% |
| Accounts Receivable | $57.0M | +14.7% |
| Current Assets | $209.8M | +2.9% |
| Total Assets | $662.8M | -3.0% |
| Current Liabilities | $192.9M | +14.0% |
| Long-term Debt | $321.5M | -8.1% |
| Total Liabilities | $516.2M | -8.0% |
| Line Item | 2026-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $55.8M | -12.2% |
| Capital Expenditures | $3.7M | +53.1% |
| Investing Cash Flow | -$20.7M | -26.2% |
| Financing Cash Flow | -$30.4M | +59.5% |
| Free Cash Flow | $52.1M | -14.8% |
| -40.4% |
| Net Income | $1.6M | +106.1% |
| EPS (Basic) | $0.01 | +104.8% |
| EPS (Diluted) | $0.01 | +104.8% |
| Stockholders' Equity |
| $146.6M |
| +20.0% |